Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
AIDS (London, England)|September 16, 2015
The dolutegravir R263K resistance mutation in HIV-1 integrase is incompatible with the emergence of resistance against raltegravirMaureen Oliveira, Thibault Mesplède, Daniela Moïsi, et al.
AIDS (London, England)|April 8, 2015
Dolutegravir inhibits HIV-1 Env evolution in primary human cellsThibault Mesplède, Daniela Moïsi, Maureen Oliveira, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
M184I/V substitutions and E138K/M184I/V double substitutions in HIV reverse transcriptase do not significantly affect the antiviral activity of EFdAMaureen Oliveira, Bluma G Brenner, Hongtao Xu, et al.
AIDS (London, England)|July 2, 2016
The M184I/V and K65R nucleoside resistance mutations in HIV-1 prevent the emergence of resistance mutations against dolutegravirMaureen Oliveira, Ruxandra I Ibanescu, Hanh Thi Pham, et al.
The Journal of Infectious Diseases|September 22, 2009
Signature nucleotide polymorphisms at positions 64 and 65 in reverse transcriptase favor the selection of the K65R resistance mutation in HIV-1 subtype CCédric F Invernizzi, Dimitrios Coutsinos, Maureen Oliveira, et al.
Antimicrobial Agents and Chemotherapy|April 21, 2010
HIV-1 protease codon 36 polymorphisms and differential development of resistance to nelfinavir, lopinavir, and atazanavir in different HIV-1 subtypesIrene Lisovsky, Susan M Schader, Jorge-Luis Martinez-Cajas, et al.
AIDS (London, England)|July 29, 2004
Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfectionBluma Brenner, Jean-Pierre Routy, Yudong Quan, et al.
Journal of Virology|June 13, 2014
Effect of HIV-1 integrase resistance mutations when introduced into SIVmac239 on susceptibility to integrase strand transfer inhibitorsSaid A Hassounah, Thibault Mesplède, Peter K Quashie, et al.
Pageof 9